EML.L

Emmerson
Emmerson PLC - Change of Nominated Advisor and Joint Broker
1st July 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4437U
Emmerson PLC
01 July 2024
 

Emmerson PLC / Ticker: EML / Index: AIM / Sector: Mining

1 July 2024

Emmerson PLC ("Emmerson" or the "Company")

 

Change of Nominated Advisor and Joint Broker

 

Emmerson PLC ("Emmerson" or the "Company"), the Moroccan focused potash development company, is pleased to announce that, following the completion of the all-share merger between Liberum Capital Limited and Panmure Gordon Group Limited, the Company has changed its Nominated Adviser and Joint Broker to Panmure Liberum Limited with immediate effect.

 

**ENDS**

 

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact:

 

Emmerson PLC

Graham Clarke / Jim Wynn / Charles Vaughan

 

+44 (0) 207 138 3204

 

Panmure Liberum Limited (Nominated Advisor and Joint Broker)

Scott Mathieson / Matthew Hogg

 

+44 (0)20 3100 2000

Shard Capital LLP (Joint Broker)

Damon Heath / Isabella Pierre

 

+44 (0)20 7186 9927

 

BlytheRay (Financial PR and IR)

Tim Blythe / Megan Ray / Said Izagaren

 

+44 (0) 207 138 3204

 

Notes to Editors

Emmerson is focused on advancing the Khemisset project ("Khemisset" or the "Project") in Morocco into a low cost, high margin supplier of potash, and the first primary producer on the African continent. With an initial 19-year life of mine, the development of Khemisset is expected to deliver long-term investment and financial contributions to Morocco including the creation of permanent employment, taxation, and a plethora of ancillary benefits. As a UK-Moroccan partnership, the Company is committed to bringing in significant international investment over the life of the mine.

Morocco is widely recognised as one of the leading phosphate producers globally, ranking third in the world in terms of tonnes produced annually, and the development of this mine is set to consolidate its position as the most important fertiliser producer in Africa. The Project has a large JORC Resource Estimate (2012) of 537Mt @ 9.24% K2O, with significant exploration potential, and is perfectly located to support the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. The need to feed the world's rapidly increasing population is driving demand for potash and Khemisset is well placed to benefit from the opportunities this presents. The Feasibility Study released in June 2020 indicated the Project has the potential to be among the lowest capital cost development stage potash projects in the world and also, as a result of its location, one of the highest margin projects. Updated financial estimates published in February 2024 indicated a net present value of US$2.2 billion, with an internal rate of return of approximately 40%.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPBUGDLCUDDGSI]]>
TwitterFacebookLinkedIn